H.E. Eng. Khalil bin Ibrahim bin Salamah, Vice Minister of Industry and Mineral Resources for Industrial Affairs, and Eng. Majed bin Rafed Al-Argoubi, CEO of the Saudi Authority for Industrial Cities and Technology Zones (MODON), joined Boston Oncology Arabia leaders and team members at the company’s Sudair manufacturing facility.
Boston Oncology Arabia welcomed H.E. Eng. Khalil bin Ibrahim bin Salamah and Eng. Majed bin Rafed Al-Argoubi to its manufacturing facility in Sudair City for Industry and Business.
During the visit, the delegation reviewed Boston Oncology Arabia’s manufacturing capabilities and ongoing operations. The tour highlighted the role of advanced local pharmaceutical manufacturing in strengthening the Kingdom’s industrial base, developing specialized technical capability, and building greater resilience into the supply of essential medicines.
The delegation toured the facility and reviewed Boston Oncology Arabia’s manufacturing operations and capabilities.
The Sudair facility is the manufacturing anchor of Boston Oncology Arabia’s integrated Saudi platform. It supports the localization of complex and high-value medicines by connecting advanced production with regulatory planning, supply readiness, and the needs of the local healthcare system.
By expanding these capabilities within the Kingdom, Boston Oncology Arabia is contributing to Saudi Vision 2030 priorities for pharmaceutical localization, technology transfer, specialized talent development, and medicine security.
Boston Oncology Arabia was honored to host the delegation and share the progress being made at Sudair. The visit reflects a shared focus on expanding high-value industrial capability and strengthening Saudi Arabia’s pharmaceutical manufacturing base.
